Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$186.58
-7.5%
$200.61
$153.58
$218.66
$330.06B0.615.78 million shs13.50 million shs
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$124.46
-5.4%
$131.18
$99.71
$141.23
$215.82B0.85.91 million shs10.78 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$153.03
-4.3%
$159.75
$140.68
$169.99
$368.77B0.477.80 million shs16.59 million shs
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
$29.68
-3.7%
$30.09
$27.25
$38.96
$35.42B0.448.84 million shs16.75 million shs
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$66.31
-2.3%
$63.25
$53.95
$76.06
$85.77B0.477.97 million shs13.79 million shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
0.00%-9.04%-11.45%+2.96%+5.21%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.00%-4.85%-7.74%+9.34%+11.81%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-6.48%-7.63%+6.13%-0.81%
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
0.00%-1.85%-5.12%-3.04%-20.58%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.00%-2.08%-0.67%+10.78%-2.44%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.6907 of 5 stars
3.53.03.33.93.42.51.3
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9608 of 5 stars
3.44.04.24.53.52.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.5205 of 5 stars
3.33.04.23.92.62.50.6
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
4.1116 of 5 stars
1.93.03.32.03.41.72.5
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
4.0793 of 5 stars
2.33.04.21.33.01.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.92
Moderate Buy$211.4513.33% Upside
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.84
Moderate Buy$137.9410.83% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.3311.96% Upside
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
1.73
Reduce$30.673.32% Upside
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
2.59
Moderate Buy$70.205.87% Upside

Current Analyst Ratings Breakdown

Latest JNJ, ABT, ABBV, KHC, and MDLZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2025
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Sell$28.00 ➝ $27.00
4/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
4/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
4/2/2025
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$64.00 ➝ $68.00
3/27/2025
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$56.00 ➝ $59.00
3/24/2025
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderweight$29.00
3/24/2025
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$69.00
3/17/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
3/10/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$133.00 ➝ $150.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
AbbVie Inc. stock logo
ABBV
AbbVie
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$210.00 ➝ $240.00
(Data available from 4/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$56.33B5.86$13.79 per share13.53$1.90 per share98.20
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$41.95B5.15$5.36 per share23.22$22.36 per share5.57
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.15$12.57 per share12.17$29.69 per share5.15
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
$25.85B1.37$3.80 per share7.82$41.27 per share0.72
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$36.44B2.35$4.71 per share14.07$20.84 per share3.18
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.28B$2.4077.7413.351.627.59%296.28%12.65%4/25/2025 (Estimated)
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$13.40B$7.6516.2721.722.5231.95%20.74%11.19%4/16/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6523.0113.822.5618.20%34.24%13.63%4/15/2025 (Estimated)
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
$2.74B$2.2613.1310.523.3910.62%7.58%4.18%4/29/2025 (Estimated)
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$4.61B$3.4219.3920.344.3412.68%16.75%6.38%4/29/2025 (Estimated)

Latest JNJ, ABT, ABBV, KHC, and MDLZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$0.67N/AN/AN/A$9.37 billionN/A
4/25/2025N/A
AbbVie Inc. stock logo
ABBV
AbbVie
$2.51N/AN/AN/A$12.91 billionN/A
4/16/2025N/A
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.07N/AN/AN/A$10.38 billionN/A
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
2/12/2025Q4 2024
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
$0.78$0.84+$0.06$1.76$6.67 billionN/A
2/4/2025Q4 2024
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$0.66$0.65-$0.01$1.30$9.66 billionN/A
1/31/2025Q4 24
AbbVie Inc. stock logo
ABBV
AbbVie
$2.98$2.16-$0.82-$0.02$14.81 billionN/A
1/22/2025Q4 2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.34$1.34N/A$5.27$11.03 billion$10.97 billion
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.563.52%+6.04%273.33%53 Years
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.361.90%+7.17%30.85%54 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.963.24%+5.43%74.59%63 Years
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
$1.605.39%N/A70.80%N/A
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
$1.882.84%+10.41%54.97%13 Years

Latest JNJ, ABT, ABBV, KHC, and MDLZ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/13/2025
AbbVie Inc. stock logo
ABBV
AbbVie
quarterly$1.643.4%4/15/20254/15/20255/15/2025
2/21/2025
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.591.75%4/15/20254/15/20255/15/2025
2/13/2025
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
quarterly$0.473.1%3/31/20253/31/20254/14/2025
2/12/2025
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
quarterly$0.405.41%3/7/20253/7/20253/28/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
17.94
0.66
0.55
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.32
1.60
1.14
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
0.39
1.06
0.59
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.58
0.68
0.48

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
78.17%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
78.32%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.08%
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
0.32%
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
0.34%
CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.76 billionOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.73 billion1.73 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable
The Kraft Heinz Company stock logo
KHC
Kraft Heinz
37,0001.19 billion1.19 billionOptionable
Mondelez International, Inc. stock logo
MDLZ
Mondelez International
90,0001.29 billion1.29 billionOptionable

Recent News About These Companies

Mondelez International (NASDAQ:MDLZ) Shares Gap Up on Analyst Upgrade

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
AbbVie stock logo

AbbVie NYSE:ABBV

$186.58 -15.06 (-7.47%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$186.80 +0.22 (+0.12%)
As of 04/4/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$124.46 -7.17 (-5.45%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$125.24 +0.78 (+0.63%)
As of 04/4/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$153.03 -6.79 (-4.25%)
Closing price 04/4/2025 03:59 PM Eastern
Extended Trading
$154.26 +1.24 (+0.81%)
As of 04/4/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Kraft Heinz stock logo

Kraft Heinz NASDAQ:KHC

$29.68 -1.13 (-3.67%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$29.88 +0.21 (+0.69%)
As of 04/4/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Kraft Heinz Company, together with its subsidiaries, manufactures and markets food and beverage products in North America and internationally. Its products include condiments and sauces, cheese and dairy products, meals, meats, refreshment beverages, coffee, and other grocery products under the Kraft, Oscar Mayer, Heinz, Philadelphia, Lunchables, Velveeta, Ore-Ida, Maxwell House, Kool-Aid, Jell-O, Heinz, ABC, Master, Quero, Kraft, Golden Circle, Wattie's, Pudliszki, and Plasmon brands. It sells its products through its own sales organizations, as well as through independent brokers, agents, and distributors to chain, wholesale, cooperative, and independent grocery accounts; convenience, value, and club stores; pharmacies and drug stores; mass merchants; foodservice distributors; institutions, including hotels, restaurants, bakeries, hospitals, health care facilities, and government agencies; and online through various e-commerce platforms and retailers. The company was formerly known as H.J. Heinz Holding Corporation and changed its name to The Kraft Heinz Company in July 2015. The Kraft Heinz Company was founded in 1869 and is based in Pittsburgh, Pennsylvania.

Mondelez International stock logo

Mondelez International NASDAQ:MDLZ

$66.31 -1.59 (-2.34%)
Closing price 04/4/2025 04:00 PM Eastern
Extended Trading
$66.23 -0.08 (-0.12%)
As of 04/4/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits and baked snacks, including cookies, crackers, salted snacks, snack bars, and cakes and pastries; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products. The company's brand portfolio includes Oreo, Ritz, LU, CLIF Bar, and Tate's Bake Shop biscuits and baked snacks, as well as Cadbury Dairy Milk, Milka, and Toblerone chocolate. It serves supermarket chains, wholesalers, supercenters, club stores, mass merchandisers, distributors, convenience stores, gasoline stations, drug stores, value stores, and other retail food outlets through direct store delivery, company-owned and satellite warehouses, distribution centers, third party distributors, and other facilities, as well as through independent sales offices and agents. The company also sells products directly to businesses and consumers through e-retail platforms, retailer digital platforms, as well as through its direct-to-consumer websites and social media platforms. Mondelez International, Inc. was formerly known as Kraft Foods Inc. and changed its name to Mondelez International, Inc. in October 2012. The company was incorporated in 2000 and is headquartered in Chicago, Illinois.